EUFECT is the lipid nanoparticle product line developed jointly by the Steinbeis-Innovationszentrum Zellkulturtechnik (SIZ) and CHESS Chemische Entwicklungs- und Synthese-Service GmbH, both based in Mannheim. It combines proprietary ionizable lipids with optimised formulations to achieve high transfection efficiency at low cytotoxicity across a broad range of cell lines. Development of new lipids at CHESS and rapid testing on cells at SIZ complement each other, and international research groups test the reagents in their own fields and feed their results back into the product development.
The three formulations below differ in the cell systems they are designed for. Detailed product information, research data and ordering are handled on the dedicated EUFECT website.
High-efficiency lipid for enhanced cellular uptake
Superior transfection efficiency
For rapidly proliferating cells
Specialised formulation for targeted delivery
For slow proliferating cells
Low toxicity
Formulation for sensitive cell systems
Very low toxicity
For sensitive cells
Reduced cellular stress
External resource
Product details, research data and ordering
The full product range, flow cytometry and fluorescence microscopy data, and the physicochemical characterisation of every batch by nanoparticle tracking analysis are documented on eufect.com. The site is operated by CHESS GmbH on behalf of the EUFECT consortium and opens in a new window.
Steinbeis-Innovationszentrum